Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma
AstraZeneca
Bruno Sangro; Peter R Galle; Robin Kate Kelley; Chaiyut Charoentum; Enrico N De Toni; Yurii Ostapenko; Jeong Heo; Ann-Lii Cheng; Andrea Wilson Woods; Charu Gupta; Jayne Abraham; Carrie L McCoy; Nikunj Patel; Alejandra Negro; Arndt Vogel; Ghassan K Abou-Alfa